All sources · 65,571 documents · Table of contents · 21st Century Cures Act · 21st Century Cures Act
Statute Compilations
21st Century Cures Act
241 entries
Sec. 1
SHORT TITLE; TABLE OF CONTENTS
Sec. 1000
SHORT TITLE
Sec. 1001
BEAU BIDEN CANCER MOONSHOT AND NIH INNOVATION PROJECTS
Sec. 1002
FDA INNOVATION PROJECTS
Sec. 1003
GRANT PROGRAM FOR STATE AND TRIBAL RESPONSE TO OPIOID USE DISORDERS
Sec. 1004
BUDGETARY TREATMENT
Sec. 2001
NATIONAL INSTITUTES OF HEALTH REAUTHORIZATION
Sec. 2002
EUREKA PRIZE COMPETITIONS
Sec. 2011
PRECISION MEDICINE INITIATIVE
Sec. 2012
PRIVACY PROTECTION FOR HUMAN RESEARCH SUBJECTS
Sec. 2013
PROTECTION OF IDENTIFIABLE AND SENSITIVE INFORMATION
Sec. 2014
DATA SHARING
Sec. 2021
INVESTING IN THE NEXT GENERATION OF RESEARCHERS
Sec. 2022
IMPROVEMENT OF LOAN REPAYMENT PROGRAM
Sec. 2031
NATIONAL INSTITUTES OF HEALTH STRATEGIC PLAN
Sec. 2032
TRIENNIAL REPORTS
Sec. 2033
INCREASING ACCOUNTABILITY AT THE NATIONAL INSTITUTES OF HEALTH
Sec. 2034
REDUCING ADMINISTRATIVE BURDEN FOR RESEARCHERS
Sec. 2035
EXEMPTION FOR THE NATIONAL INSTITUTES OF HEALTH FROM THE PAPERWORK REDUCTION ACT REQUIREMENTS
Sec. 2036
HIGH-RISK, HIGH-REWARD RESEARCH
Sec. 2037
NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES
Sec. 2038
COLLABORATION AND COORDINATION TO ENHANCE RESEARCH
Sec. 2039
ENHANCING THE RIGOR AND REPRODUCIBILITY OF SCIENTIFIC RESEARCH
Sec. 2040
IMPROVING MEDICAL REHABILITATION RESEARCH AT THE NATIONAL INSTITUTES OF HEALTH
Sec. 2041
TASK FORCE ON RESEARCH SPECIFIC TO PREGNANT WOMEN AND LACTATING WOMEN
Sec. 2042
STREAMLINING NATIONAL INSTITUTES OF HEALTH REPORTING REQUIREMENTS
Sec. 2043
REIMBURSEMENT FOR RESEARCH SUBSTANCES AND LIVING ORGANISMS
Sec. 2044
SENSE OF CONGRESS ON INCREASED INCLUSION OF UNDERREPRESENTED POPULATIONS IN CLINICAL TRIALS
Sec. 2051
TECHNICAL UPDATES TO CLINICAL TRIALS DATABASE
Sec. 2052
COMPLIANCE ACTIVITIES REPORTS
Sec. 2053
UPDATES TO POLICIES TO IMPROVE DATA
Sec. 2054
CONSULTATION
Sec. 2061
NATIONAL NEUROLOGICAL CONDITIONS SURVEILLANCE SYSTEM
Sec. 2062
TICK-BORNE DISEASES
Sec. 2063
ACCESSING, SHARING, AND USING HEALTH DATA FOR RESEARCH PURPOSES
Sec. 2071
NATIONAL PEDIATRIC RESEARCH NETWORK
Sec. 2072
GLOBAL PEDIATRIC CLINICAL STUDY NETWORK
Sec. 3001
PATIENT EXPERIENCE DATA
Sec. 3002
PATIENT-FOCUSED DRUG DEVELOPMENT GUIDANCE
Sec. 3003
STREAMLINING PATIENT INPUT
Sec. 3004
REPORT ON PATIENT EXPERIENCE DRUG DEVELOPMENT
Sec. 3011
QUALIFICATION OF DRUG DEVELOPMENT TOOLS
Sec. 3012
TARGETED DRUGS FOR RARE DISEASES
Sec. 3013
REAUTHORIZATION OF PROGRAM TO ENCOURAGE TREATMENTS FOR RARE PEDIATRIC DISEASES
Sec. 3014
GAO STUDY OF PRIORITY REVIEW VOUCHER PROGRAMS
Sec. 3015
AMENDMENTS TO THE ORPHAN DRUG GRANTS
Sec. 3016
NATIONAL CENTERS OF EXCELLENCE IN ADVANCED AND CONTINUOUS PHARMACEUTICAL MANUFACTURING
Sec. 3021
NOVEL CLINICAL TRIAL DESIGNS
Sec. 3022
REAL WORLD EVIDENCE
Sec. 3023
PROTECTION OF HUMAN RESEARCH SUBJECTS
Sec. 3024
INFORMED CONSENT WAIVER OR ALTERATION FOR CLINICAL INVESTIGATIONS
Sec. 3031
SUMMARY LEVEL REVIEW
Sec. 3032
EXPANDED ACCESS POLICY
Sec. 3033
ACCELERATED APPROVAL FOR REGENERATIVE ADVANCED THERAPIES
Sec. 3034
GUIDANCE REGARDING DEVICES USED IN THE RECOVERY, ISOLATION, OR DELIVERY OF REGENERATIVE ADVANCED THERAPIES
Sec. 3035
REPORT ON REGENERATIVE ADVANCED THERAPIES
Sec. 3036
STANDARDS FOR REGENERATIVE MEDICINE AND REGENERATIVE ADVANCED THERAPIES
Sec. 3037
HEALTH CARE ECONOMIC INFORMATION
Sec. 3038
COMBINATION PRODUCT INNOVATION
Sec. 3041
ANTIMICROBIAL RESISTANCE MONITORING
Sec. 3042
LIMITED POPULATION PATHWAY
Sec. 3043
PRESCRIBING AUTHORITY
Sec. 3044
SUSCEPTIBILITY TEST INTERPRETIVE CRITERIA FOR MICROORGANISMS; ANTIMICROBIAL SUSCEPTIBILITY TESTING DEVICES
Sec. 3051
BREAKTHROUGH DEVICES
Sec. 3052
HUMANITARIAN DEVICE EXEMPTION
Sec. 3053
RECOGNITION OF STANDARDS
Sec. 3054
CERTAIN CLASS I AND CLASS II DEVICES
Sec. 3055
CLASSIFICATION PANELS
Sec. 3056
INSTITUTIONAL REVIEW BOARD FLEXIBILITY
Sec. 3057
CLIA WAIVER IMPROVEMENTS
Sec. 3058
LEAST BURDENSOME DEVICE REVIEW
Sec. 3059
CLEANING INSTRUCTIONS AND VALIDATION DATA REQUIREMENT
Sec. 3060
CLARIFYING MEDICAL SOFTWARE REGULATION
Sec. 3071
SILVIO O. CONTE SENIOR BIOMEDICAL RESEARCH AND BIOMEDICAL PRODUCT ASSESSMENT SERVICE
Sec. 3072
HIRING AUTHORITY FOR SCIENTIFIC, TECHNICAL, AND PROFESSIONAL PERSONNEL
Sec. 3073
ESTABLISHMENT OF FOOD AND DRUG ADMINISTRATION INTERCENTER INSTITUTES
Sec. 3074
SCIENTIFIC ENGAGEMENT
Sec. 3075
DRUG SURVEILLANCE
Sec. 3076
REAGAN-UDALL FOUNDATION FOR THE FOOD AND DRUG ADMINISTRATION
Sec. 3081
MEDICAL COUNTERMEASURE GUIDELINES
Sec. 3082
CLARIFYING BARDA CONTRACTING AUTHORITY
Sec. 3083
COUNTERMEASURE BUDGET PLAN
Sec. 3084
MEDICAL COUNTERMEASURES INNOVATION
Sec. 3085
STREAMLINING PROJECT BIOSHIELD PROCUREMENT
Sec. 3086
ENCOURAGING TREATMENTS FOR AGENTS THAT PRESENT A NATIONAL SECURITY THREAT
Sec. 3087
PAPERWORK REDUCTION ACT WAIVER DURING A PUBLIC HEALTH EMERGENCY
Sec. 3088
CLARIFYING FOOD AND DRUG ADMINISTRATION EMERGENCY USE AUTHORIZATION
Sec. 3091
PREDICTABLE REVIEW TIMELINES OF VACCINES BY THE ADVISORY COMMITTEE ON IMMUNIZATION PRACTICES
Sec. 3092
REVIEW OF PROCESSES AND CONSISTENCY OF ADVISORY COMMITTEE ON IMMUNIZATION PRACTICES RECOMMENDATIONS
Sec. 3093
ENCOURAGING VACCINE INNOVATION
Sec. 3101
TECHNICAL CORRECTIONS
Sec. 3102
COMPLETED STUDIES
Sec. 4001
ASSISTING DOCTORS AND HOSPITALS IN IMPROVING QUALITY OF CARE FOR PATIENTS
Sec. 4002
TRANSPARENT REPORTING ON USABILITY, SECURITY, AND FUNCTIONALITY
Sec. 4003
INTEROPERABILITY
Sec. 4004
INFORMATION BLOCKING
Sec. 4005
LEVERAGING ELECTRONIC HEALTH RECORDS TO IMPROVE PATIENT CARE
Sec. 4006
EMPOWERING PATIENTS AND IMPROVING PATIENT ACCESS TO THEIR ELECTRONIC HEALTH INFORMATION
Sec. 4007
GAO STUDY ON PATIENT MATCHING
Sec. 4008
GAO STUDY ON PATIENT ACCESS TO HEALTH INFORMATION
Sec. 4009
IMPROVING MEDICARE LOCAL COVERAGE DETERMINATIONS
Sec. 4010
MEDICARE PHARMACEUTICAL AND TECHNOLOGY OMBUDSMAN
Sec. 4011
MEDICARE SITE-OF-SERVICE PRICE TRANSPARENCY
Sec. 4012
TELEHEALTH SERVICES IN MEDICARE
Sec. 5001
SAVINGS IN THE MEDICARE IMPROVEMENT FUND
Sec. 5002
MEDICAID REIMBURSEMENT TO STATES FOR DURABLE MEDICAL EQUIPMENT
Sec. 5003
PENALTIES FOR VIOLATIONS OF GRANTS, CONTRACTS, AND OTHER AGREEMENTS
Sec. 5004
REDUCING OVERPAYMENTS OF INFUSION DRUGS
Sec. 5005
INCREASING OVERSIGHT OF TERMINATION OF MEDICAID PROVIDERS
Sec. 5006
REQUIRING PUBLICATION OF FEE-FOR-SERVICE PROVIDER DIRECTORY
Sec. 5007
FAIRNESS IN MEDICAID SUPPLEMENTAL NEEDS TRUSTS
Sec. 5008
ELIMINATING FEDERAL FINANCIAL PARTICIPATION WITH RESPECT TO EXPENDITURES UNDER MEDICAID FOR AGENTS USED FOR COSMETIC PURPOSES OR HAIR GROWTH
Sec. 5009
AMENDMENT TO THE PREVENTION AND PUBLIC HEALTH FUND
Sec. 5010
STRATEGIC PETROLEUM RESERVE DRAWDOWN
Sec. 5011
RESCISSION OF PORTION OF ACA TERRITORY FUNDING
Sec. 5012
MEDICARE COVERAGE OF HOME INFUSION THERAPY
Sec. 6000
SHORT TITLE
Sec. 6001
ASSISTANT SECRETARY FOR MENTAL HEALTH AND SUBSTANCE USE
Sec. 6002
STRENGTHENING THE LEADERSHIP OF THE SUBSTANCE ABUSE AND MENTAL HEALTH SERVICES ADMINISTRATION
Sec. 6003
CHIEF MEDICAL OFFICER
Sec. 6004
IMPROVING THE QUALITY OF BEHAVIORAL HEALTH PROGRAMS
Sec. 6005
STRATEGIC PLAN
Sec. 6006
BIENNIAL REPORT CONCERNING ACTIVITIES AND PROGRESS
Sec. 6007
AUTHORITIES OF CENTERS FOR MENTAL HEALTH SERVICES, SUBSTANCE ABUSE PREVENTION, AND SUBSTANCE ABUSE TREATMENT
Sec. 6008
ADVISORY COUNCILS
Sec. 6009
PEER REVIEW
Sec. 6021
IMPROVING OVERSIGHT OF MENTAL AND SUBSTANCE USE DISORDERS PROGRAMS THROUGH THE ASSISTANT SECRETARY FOR PLANNING AND EVALUATION
Sec. 6022
REPORTING FOR PROTECTION AND ADVOCACY ORGANIZATIONS
Sec. 6023
GAO STUDY
Sec. 7001
ENCOURAGING INNOVATION AND EVIDENCE-BASED PROGRAMS
Sec. 7002
PROMOTING ACCESS TO INFORMATION ON EVIDENCE-BASED PROGRAMS AND PRACTICES
Sec. 7003
PRIORITY MENTAL HEALTH NEEDS OF REGIONAL AND NATIONAL SIGNIFICANCE
Sec. 7004
PRIORITY SUBSTANCE USE DISORDER TREATMENT NEEDS OF REGIONAL AND NATIONAL SIGNIFICANCE
Sec. 7005
PRIORITY SUBSTANCE USE DISORDER PREVENTION NEEDS OF REGIONAL AND NATIONAL SIGNIFICANCE
Sec. 8001
COMMUNITY MENTAL HEALTH SERVICES BLOCK GRANT
Sec. 8002
SUBSTANCE ABUSE PREVENTION AND TREATMENT BLOCK GRANT
Sec. 8003
ADDITIONAL PROVISIONS RELATED TO THE BLOCK GRANTS
Sec. 8004
STUDY OF DISTRIBUTION OF FUNDS UNDER THE SUBSTANCE ABUSE PREVENTION AND TREATMENT BLOCK GRANT AND THE COMMUNITY MENTAL HEALTH SERVICES BLOCK GRANT
Sec. 9001
GRANTS FOR TREATMENT AND RECOVERY FOR HOMELESS INDIVIDUALS
Sec. 9002
GRANTS FOR JAIL DIVERSION PROGRAMS
Sec. 9003
PROMOTING INTEGRATION OF PRIMARY AND BEHAVIORAL HEALTH CARE
Sec. 9004
PROJECTS FOR ASSISTANCE IN TRANSITION FROM HOMELESSNESS
Sec. 9005
NATIONAL SUICIDE PREVENTION LIFELINE PROGRAM
Sec. 9006
CONNECTING INDIVIDUALS AND FAMILIES WITH CARE
Sec. 9007
STRENGTHENING COMMUNITY CRISIS RESPONSE SYSTEMS
Sec. 9008
GARRETT LEE SMITH MEMORIAL ACT REAUTHORIZATION
Sec. 9009
ADULT SUICIDE PREVENTION
Sec. 9010
MENTAL HEALTH AWARENESS TRAINING GRANTS
Sec. 9011
SENSE OF CONGRESS ON PRIORITIZING AMERICAN INDIANS AND ALASKA NATIVE YOUTH WITHIN SUICIDE PREVENTION PROGRAMS
Sec. 9012
EVIDENCE-BASED PRACTICES FOR OLDER ADULTS
Sec. 9013
NATIONAL VIOLENT DEATH REPORTING SYSTEM
Sec. 9014
ASSISTED OUTPATIENT TREATMENT
Sec. 9015
ASSERTIVE COMMUNITY TREATMENT GRANT PROGRAM
Sec. 9016
SOBER TRUTH ON PREVENTING UNDERAGE DRINKING REAUTHORIZATION
Sec. 9017
CENTER AND PROGRAM REPEALS
Sec. 9021
MENTAL AND BEHAVIORAL HEALTH EDUCATION AND TRAINING GRANTS
Sec. 9022
STRENGTHENING THE MENTAL AND SUBSTANCE USE DISORDERS WORKFORCE
Sec. 9023
CLARIFICATION ON CURRENT ELIGIBILITY FOR LOAN REPAYMENT PROGRAMS
Sec. 9024
MINORITY FELLOWSHIP PROGRAM
Sec. 9025
LIABILITY PROTECTIONS FOR HEALTH PROFESSIONAL VOLUNTEERS AT COMMUNITY HEALTH CENTERS
Sec. 9026
REPORTS
Sec. 9031
MENTAL HEALTH AND SUBSTANCE USE DISORDER SERVICES ON CAMPUS
Sec. 9032
INTERAGENCY WORKING GROUP ON COLLEGE MENTAL HEALTH
Sec. 9033
IMPROVING MENTAL HEALTH ON COLLEGE CAMPUSES
Sec. 10001
PROGRAMS FOR CHILDREN WITH A SERIOUS EMOTIONAL DISTURBANCE
Sec. 10002
INCREASING ACCESS TO PEDIATRIC MENTAL HEALTH CARE
Sec. 10003
SUBSTANCE USE DISORDER TREATMENT AND EARLY INTERVENTION SERVICES FOR CHILDREN AND ADOLESCENTS
Sec. 10004
CHILDREN’S RECOVERY FROM TRAUMA
Sec. 10005
SCREENING AND TREATMENT FOR MATERNAL DEPRESSION
Sec. 10006
INFANT AND EARLY CHILDHOOD MENTAL HEALTH PROMOTION, INTERVENTION, AND TREATMENT
Sec. 11001
SENSE OF CONGRESS
Sec. 11002
CONFIDENTIALITY OF RECORDS
Sec. 11003
CLARIFICATION ON PERMITTED USES AND DISCLOSURES OF PROTECTED HEALTH INFORMATION
Sec. 11004
DEVELOPMENT AND DISSEMINATION OF MODEL TRAINING PROGRAMS
Sec. 12001
RULE OF CONSTRUCTION RELATED TO MEDICAID COVERAGE OF MENTAL HEALTH SERVICES AND PRIMARY CARE SERVICES FURNISHED ON THE SAME DAY
Sec. 12002
STUDY AND REPORT RELATED TO MEDICAID MANAGED CARE REGULATION
Sec. 12003
GUIDANCE ON OPPORTUNITIES FOR INNOVATION
Sec. 12004
STUDY AND REPORT ON MEDICAID EMERGENCY PSYCHIATRIC DEMONSTRATION PROJECT
Sec. 12005
PROVIDING EPSDT SERVICES TO CHILDREN IN IMDS
Sec. 12006
ELECTRONIC VISIT VERIFICATION SYSTEM REQUIRED FOR PERSONAL CARE SERVICES AND HOME HEALTH CARE SERVICES UNDER MEDICAID
Sec. 13001
ENHANCED COMPLIANCE WITH MENTAL HEALTH AND SUBSTANCE USE DISORDER COVERAGE REQUIREMENTS
Sec. 13002
ACTION PLAN FOR ENHANCED ENFORCEMENT OF MENTAL HEALTH AND SUBSTANCE USE DISORDER COVERAGE
Sec. 13003
REPORT ON INVESTIGATIONS REGARDING PARITY IN MENTAL HEALTH AND SUBSTANCE USE DISORDER BENEFITS
Sec. 13004
GAO STUDY ON PARITY IN MENTAL HEALTH AND SUBSTANCE USE DISORDER BENEFITS
Sec. 13005
INFORMATION AND AWARENESS ON EATING DISORDERS
Sec. 13006
EDUCATION AND TRAINING ON EATING DISORDERS
Sec. 13007
CLARIFICATION OF EXISTING PARITY RULES
Sec. 14001
LAW ENFORCEMENT GRANTS FOR CRISIS INTERVENTION TEAMS, MENTAL HEALTH PURPOSES
Sec. 14002
ASSISTED OUTPATIENT TREATMENT PROGRAMS
Sec. 14003
FEDERAL DRUG AND MENTAL HEALTH COURTS
Sec. 14004
MENTAL HEALTH IN THE JUDICIAL SYSTEM
Sec. 14005
FORENSIC ASSERTIVE COMMUNITY TREATMENT INITIATIVES
Sec. 14006
ASSISTANCE FOR INDIVIDUALS TRANSITIONING OUT OF SYSTEMS
Sec. 14007
CO-OCCURRING SUBSTANCE ABUSE AND MENTAL HEALTH CHALLENGES IN DRUG COURTS
Sec. 14008
MENTAL HEALTH TRAINING FOR FEDERAL UNIFORMED SERVICES
Sec. 14009
ADVANCING MENTAL HEALTH AS PART OF OFFENDER REENTRY
Sec. 14010
SCHOOL MENTAL HEALTH CRISIS INTERVENTION TEAMS
Sec. 14011
ACTIVE-SHOOTER TRAINING FOR LAW ENFORCEMENT
Sec. 14012
CO-OCCURRING SUBSTANCE ABUSE AND MENTAL HEALTH CHALLENGES IN RESIDENTIAL SUBSTANCE ABUSE TREATMENT PROGRAMS
Sec. 14013
MENTAL HEALTH AND DRUG TREATMENT ALTERNATIVES TO INCARCERATION PROGRAMS
Sec. 14014
NATIONAL CRIMINAL JUSTICE AND MENTAL HEALTH TRAINING AND TECHNICAL ASSISTANCE
Sec. 14015
IMPROVING DEPARTMENT OF JUSTICE DATA COLLECTION ON MENTAL ILLNESS INVOLVED IN CRIME
Sec. 14016
REPORTS ON THE NUMBER OF MENTALLY ILL OFFENDERS IN PRISON
Sec. 14017
CODIFICATION OF DUE PROCESS FOR DETERMINATIONS BY SECRETARY OF VETERANS AFFAIRS OF MENTAL CAPACITY OF BENEFICIARIES
Sec. 14018
REAUTHORIZATION OF APPROPRIATIONS
Sec. 14021
SEQUENTIAL INTERCEPT MODEL
Sec. 14022
PRISON AND JAILS
Sec. 14023
ALLOWABLE USES
Sec. 14024
LAW ENFORCEMENT TRAINING
Sec. 14025
FEDERAL LAW ENFORCEMENT TRAINING
Sec. 14026
GAO REPORT
Sec. 14027
EVIDENCE BASED PRACTICES
Sec. 14028
TRANSPARENCY, PROGRAM ACCOUNTABILITY, AND ENHANCEMENT OF LOCAL AUTHORITY
Sec. 14029
GRANT ACCOUNTABILITY
Sec. 15000
SHORT TITLE
Sec. 15001
DEVELOPMENT OF MEDICARE HCPCS VERSION OF MS-DRG CODES FOR SIMILAR HOSPITAL SERVICES
Sec. 15002
ESTABLISHING BENEFICIARY EQUITY IN THE MEDICARE HOSPITAL READMISSION PROGRAM
Sec. 15003
FIVE-YEAR EXTENSION OF THE RURAL COMMUNITY HOSPITAL DEMONSTRATION PROGRAM
Sec. 15004
REGULATORY RELIEF FOR LTCHS
Sec. 15005
SAVINGS FROM IPPS MACRA PAY-FOR THROUGH NOT APPLYING DOCUMENTATION AND CODING ADJUSTMENTS
Sec. 15006
EXTENSION OF CERTAIN LTCH MEDICARE PAYMENT RULES
Sec. 15007
APPLICATION OF RULES ON THE CALCULATION OF HOSPITAL LENGTH OF STAY TO ALL LTCHS
Sec. 15008
CHANGE IN MEDICARE CLASSIFICATION FOR CERTAIN HOSPITALS
Sec. 15009
TEMPORARY EXCEPTION TO THE APPLICATION OF THE MEDICARE LTCH SITE NEUTRAL PROVISIONS FOR CERTAIN SPINAL CORD SPECIALTY HOSPITALS
Sec. 15010
TEMPORARY EXTENSION TO THE APPLICATION OF THE MEDICARE LTCH SITE NEUTRAL PROVISIONS FOR CERTAIN DISCHARGES WITH SEVERE WOUNDS
Sec. 16001
CONTINUING MEDICARE PAYMENT UNDER HOPD PROSPECTIVE PAYMENT SYSTEM FOR SERVICES FURNISHED BY MID-BUILD OFF-CAMPUS OUTPATIENT DEPARTMENTS OF PROVIDERS
Sec. 16002
TREATMENT OF CANCER HOSPITALS IN OFF-CAMPUS OUTPATIENT DEPARTMENT OF A PROVIDER POLICY
Sec. 16003
TREATMENT OF ELIGIBLE PROFESSIONALS IN AMBULATORY SURGICAL CENTERS FOR MEANINGFUL USE AND MIPS
Sec. 16004
CONTINUING ACCESS TO HOSPITALS ACT OF 2016
Sec. 16005
DELAY OF IMPLEMENTATION OF MEDICARE FEE SCHEDULE ADJUSTMENTS FOR WHEELCHAIR ACCESSORIES AND SEATING SYSTEMS WHEN USED IN CONJUNCTION WITH COMPLEX REHABILITATION TECHNOLOGY (CRT) WHEELCHAIRS
Sec. 16006
ALLOWING PHYSICAL THERAPISTS TO UTILIZE LOCUM TENENS ARRANGEMENTS UNDER MEDICARE
Sec. 16007
EXTENSION OF THE TRANSITION TO NEW PAYMENT RATES FOR DURABLE MEDICAL EQUIPMENT UNDER THE MEDICARE PROGRAM
Sec. 16008
REQUIREMENTS IN DETERMINING ADJUSTMENTS USING INFORMATION FROM COMPETITIVE BIDDING PROGRAMS
Sec. 17001
DELAY IN AUTHORITY TO TERMINATE CONTRACTS FOR MEDICARE ADVANTAGE PLANS FAILING TO ACHIEVE MINIMUM QUALITY RATINGS
Sec. 17002
REQUIREMENT FOR ENROLLMENT DATA REPORTING FOR MEDICARE
Sec. 17003
UPDATING THE WELCOME TO MEDICARE PACKAGE
Sec. 17004
NO PAYMENT FOR ITEMS AND SERVICES FURNISHED BY NEWLY ENROLLED PROVIDERS OR SUPPLIERS WITHIN A TEMPORARY MORATORIUM AREA
Sec. 17005
PRESERVATION OF MEDICARE BENEFICIARY CHOICE UNDER MEDICARE ADVANTAGE
Sec. 17006
ALLOWING END-STAGE RENAL DISEASE BENEFICIARIES TO CHOOSE A MEDICARE ADVANTAGE PLAN
Sec. 17007
IMPROVEMENTS TO THE ASSIGNMENT OF BENEFICIARIES UNDER THE MEDICARE SHARED SAVINGS PROGRAM
Sec. 18001
EXCEPTION FROM GROUP HEALTH PLAN REQUIREMENTS FOR QUALIFIED SMALL EMPLOYER HEALTH REIMBURSEMENT ARRANGEMENTS